237 related articles for article (PubMed ID: 10888597)
1. Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome.
Dixon J; Brakebusch C; Fässler R; Dixon MJ
Hum Mol Genet; 2000 Jun; 9(10):1473-80. PubMed ID: 10888597
[TBL] [Abstract][Full Text] [Related]
2. Treacher Collins syndrome: unmasking the role of Tcof1/treacle.
Sakai D; Trainor PA
Int J Biochem Cell Biol; 2009 Jun; 41(6):1229-32. PubMed ID: 19027870
[TBL] [Abstract][Full Text] [Related]
3. Treacher Collins syndrome.
Dixon J; Trainor P; Dixon MJ
Orthod Craniofac Res; 2007 May; 10(2):88-95. PubMed ID: 17552945
[TBL] [Abstract][Full Text] [Related]
4. Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
Dixon J; Jones NC; Sandell LL; Jayasinghe SM; Crane J; Rey JP; Dixon MJ; Trainor PA
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13403-8. PubMed ID: 16938878
[TBL] [Abstract][Full Text] [Related]
5. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
Calo E; Gu B; Bowen ME; Aryan F; Zalc A; Liang J; Flynn RA; Swigut T; Chang HY; Attardi LD; Wysocka J
Nature; 2018 Feb; 554(7690):112-117. PubMed ID: 29364875
[TBL] [Abstract][Full Text] [Related]
6. Genetic background has a major effect on the penetrance and severity of craniofacial defects in mice heterozygous for the gene encoding the nucleolar protein Treacle.
Dixon J; Dixon MJ
Dev Dyn; 2004 Apr; 229(4):907-14. PubMed ID: 15042714
[TBL] [Abstract][Full Text] [Related]
7. Treacher Collins syndrome with a de Novo 5-bp deletion in the TCOF1 gene.
Su PH; Chen JY; Chen SJ; Yu JS
J Formos Med Assoc; 2006 Jun; 105(6):518-21. PubMed ID: 16801042
[TBL] [Abstract][Full Text] [Related]
8. Fishing the molecular bases of Treacher Collins syndrome.
Weiner AM; Scampoli NL; Calcaterra NB
PLoS One; 2012; 7(1):e29574. PubMed ID: 22295061
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the TCOF1 gene in 11 Japanese patients with Treacher Collins Syndrome and mechanism of mutagenesis.
Horiuchi K; Ariga T; Fujioka H; Kawashima K; Yamamoto Y; Igawa H; Sugihara T; Sakiyama Y
Am J Med Genet A; 2005 May; 134(4):363-7. PubMed ID: 15759264
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the Treacher Collins syndrome gene lead to mislocalization of the nucleolar protein treacle.
Marsh KL; Dixon J; Dixon MJ
Hum Mol Genet; 1998 Oct; 7(11):1795-800. PubMed ID: 9736782
[TBL] [Abstract][Full Text] [Related]
11. Another face of the Treacher Collins syndrome (TCOF1) gene: identification of additional exons.
So RB; Gonzales B; Henning D; Dixon J; Dixon MJ; Valdez BC
Gene; 2004 Mar; 328():49-57. PubMed ID: 15019983
[TBL] [Abstract][Full Text] [Related]
12. TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins Syndrome throughout its coding region.
Wise CA; Chiang LC; Paznekas WA; Sharma M; Musy MM; Ashley JA; Lovett M; Jabs EW
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3110-5. PubMed ID: 9096354
[TBL] [Abstract][Full Text] [Related]
13. Face off against ROS: Tcof1/Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development.
Sakai D; Trainor PA
Dev Growth Differ; 2016 Sep; 58(7):577-85. PubMed ID: 27481486
[TBL] [Abstract][Full Text] [Related]
14. POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4.
Sanchez E; Laplace-Builhé B; Mau-Them FT; Richard E; Goldenberg A; Toler TL; Guignard T; Gatinois V; Vincent M; Blanchet C; Boland A; Bihoreau MT; Deleuze JF; Olaso R; Nephi W; Lüdecke HJ; Verheij JBGM; Moreau-Lenoir F; Denoyelle F; Rivière JB; Laplanche JL; Willing M; Captier G; Apparailly F; Wieczorek D; Collet C; Djouad F; Geneviève D
Genet Med; 2020 Mar; 22(3):547-556. PubMed ID: 31649276
[TBL] [Abstract][Full Text] [Related]
15. Treacher Collins Syndrome: the genetics of a craniofacial disease.
Kadakia S; Helman SN; Badhey AK; Saman M; Ducic Y
Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):893-8. PubMed ID: 24690222
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, treatment and genetic background of Treacher Collins syndrome.
Marszałek B; Wójcicki P; Kobus K; Trzeciak WH
J Appl Genet; 2002; 43(2):223-33. PubMed ID: 12080178
[TBL] [Abstract][Full Text] [Related]
17. Tcof1-Related Molecular Networks in Treacher Collins Syndrome.
Dai J; Si J; Wang M; Huang L; Fang B; Shi J; Wang X; Shen G
J Craniofac Surg; 2016 Sep; 27(6):1420-6. PubMed ID: 27300466
[TBL] [Abstract][Full Text] [Related]
18. The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor.
Valdez BC; Henning D; So RB; Dixon J; Dixon MJ
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10709-14. PubMed ID: 15249688
[TBL] [Abstract][Full Text] [Related]
19. Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients.
Masotti C; Ornelas CC; Splendore-Gordonos A; Moura R; Félix TM; Alonso N; Camargo AA; Passos-Bueno MR
BMC Med Genet; 2009 Dec; 10():136. PubMed ID: 20003452
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
Sakai D; Dixon J; Achilleos A; Dixon M; Trainor PA
Nat Commun; 2016 Jan; 7():10328. PubMed ID: 26792133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
